About us

Bionevia Pharmaceuticals Inc. is a company that focuses on the discovery, development, and commercialization of products for the treatment of patients with central nervous system (CNS) and pain disorders.

Bionevia is targeting large therapeutic markets with significant unmet needs. The company is developing compounds which combine low risk and differentiated profiles that will make them successful competitors in their respective markets.

In addition, the company has established collaboration agreements and partnerships to build a portfolio of novel products with improved therapeutic properties and/or reduced negative side effects.